alexa Socioeconomic Impact of Primary Open Angle Glaucoma in Mexico | OMICS International
ISSN: 2155-9570
Journal of Clinical & Experimental Ophthalmology

Like us on:

Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Socioeconomic Impact of Primary Open Angle Glaucoma in Mexico

Eduardo García Luna1, Alejandro Sámano Guerrero2*, Carlos Alberto Romo Arpio3, Pablo Villarreal Guerra4 and Rogelio Villarreal Villarreal1

1División de Ciencias de la Salud UDEM, Mexico

2Fundación Ojos para México, Arturo Adrián Martínez Ibarra MD Fundación Ojos para México

3Centro Oftalmológico del Valle, México

4División Ciencias de la Salud Oftalmología UDEM, México

*Corresponding Author:
Alejandro Sámano Guerrero
Fundación Ojos para México
Santos Degollado Sur 306 Col. Nuevo Obispado
Monterrey, NL, C.P. 64040,México
Tel: +011528182802382
Fax: +011528186756891
E-mail: [email protected]

Received date: June 13, 2016; Accepted date: July 18, 2016; Published date: July 21, 2016

Citation: Luna EG, Guerrero AS, Arpio CAR, Guerra PV, Villarreal RV (2016) Socioeconomic Impact of Primary Open Angle Glaucoma in Mexico. J Clin Exp Ophthalmol 7:575. doi:10.4172/2155-9570.1000575

Copyright: © 2016 Luna EG, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Clinical & Experimental Ophthalmology

Abstract

By means of a transversal study we have estimated the yearly cost for each patient with primary open angle glaucoma and the economic effects on Mexican society and in the family of the patients. The direct costs (diagnosis and treatment) and indirect costs (productivity losses) were calculated with an exploratory study that involved the biggest 30 population areas in Mexico. The total costs are $1,144,611,537 USD during the first year for an estimated prevalence of primary open angle glaucoma with visual disability in our country reported previously. An appropriate detecting method for primary open angle glaucoma that is time and cost saving is yet to be planned and implemented in Mexico.

Keywords

Open angle glaucoma; Mexico

Short Communication

The authors of this work are a university ophthalmology research group from Monterrey, Nuevo Leon, Mexico. Our purpose is to bring new knowledge in the areas of General and Subspecialized Ophthalmology. We work besides Universidad de Monterrey, one of the most important universities in our country in the search of better ocular diseases understanding in Mexico and in the world.

In a transversal study we collected data about costs of primary angle glaucoma for the Mexican society and for patients and the patients’ family altogether [1]. Direct and indirect costs for the disease were calculated. Direct costs were defined as the costs that are absorbed by the health social institutions and those included were first evaluation ophthalmological consult, diagnostic tests, follow-up and treatment (surgical procedures not taken into account). The prices for each of these elements were obtained through a telephonic survey and the calculation of a mean price in the 30 most populated areas in the country. Indirect costs were calculated with the mean base salary per day lost and the price of caretaking services with a prevalence of glaucoma previously reported by the LALES [2] study and the expected blind population estimated for primary open angle glaucoma bearers reported by Quigley [3].

The total direct cost for each patient ascends to $887 USD each year and up to $3,540 USD in 5 years. These numbers multiplied with the quantity of disabled patients by primary open angle glaucoma sums up to $626,367,505 USD of yearly direct cost. The indirect costs include the productivity losses produced by the non-capable working disabled patient and the caretaking costs that these patients need. The calculated yearly indirect cost of all the disabled primary open angle glaucoma bearers is $518,244,032 USD. The total amount spent each year by the Mexican society is $1,144,611,537 USD for all the visually limited primary angle glaucoma patients. In 5 years this quantity goes up to $5,723,057,685 USD.

In our not yet published work "Primary open angle glaucoma prevalence in patients over 40 years in a diagnostic campaign simulacrum" we find the same limitations in the actual work-up for glaucoma diagnosis and treatment. In the present time there is no cost and time effective method for detecting glaucoma in a large-scale manner inside a population, a fast and low-cost technology is extremely needed to diagnose open angle glaucoma patients in an early stage and at the same time prevent disease complications. None of the found primary open angle glaucoma patients in our study had an elevated intraocular pressure. Pharmacological glaucoma treatment is also unreliable and it has been demonstrated that optic nerve damage can progress even when intraocular pressure is within normal range, thus we believe that future open angle glaucoma research should be focused in a neurological origin of the disease. An appropriate management for primary open angle glaucoma is yet to be found mainly in developing countries in the world. This management needs to be sustainable for the health care institutions for each of those countries.

In conclusion, primary open angle glaucoma is an expensive disease for Mexican society and healthcare providers in behalf of the still costly diagnosis and treatment methods that actually exist.

Conflict of Interests

The authors did not receive any financial support from any public or private sources. The authors have no financial or proprietary interest in a product, method, or material described herein. No conflicting relationship exists for any author. All authors grant their acknowledgment in the participation in this work.

References

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Article Usage

  • Total views: 9063
  • [From(publication date):
    August-2016 - Jul 20, 2018]
  • Breakdown by view type
  • HTML page views : 8966
  • PDF downloads : 97
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7